Fluorescence contrast-enhanced proliferative lesion imaging by enema administration of indocyanine green in a rat model of colon carcinogenesis

The fluorescent contrast agent indocyanine green (ICG) is approved by the Food and Drug Administration for clinical applications. We previously reported that cultured human colon tumor cells preferentially take up ICG by endocytic activity in association with disruption of their tight junctions. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Onda, Nobuhiko, Mizutani-Morita, Reiko, Yamashita, Susumu, Nagahara, Rei, Matsumoto, Shinya, Yoshida, Toshinori, Shibutani, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685748/
https://www.ncbi.nlm.nih.gov/pubmed/29163827
http://dx.doi.org/10.18632/oncotarget.21744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685748/
https://www.ncbi.nlm.nih.gov/pubmed/29163827
http://dx.doi.org/10.18632/oncotarget.21744

Ejemplares similares